# Xanax XR

NDC: 58151-506
Generic name: alprazolam
Labeler / Manufacturer: Viatris Specialty LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, EXTENDED RELEASE
Routes: ORAL
Marketing started: 20240726
Marketing ended: 20270228
FDA application: NDA021434

## Active ingredients

- ALPRAZOLAM: 3 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"58151-506"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=58151-506
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c8990714-c2f5-4b0c-9f1c-91d77156d962
